“Chasing the high” – Experiences of ethylphenidate as described on international internet forums

Substance Abuse: Research and Treatment

Volumn 9, Issue , 2015, Pages 9-16

  Soussan, Christophe ^a   Kjellgren, Anette ^a  

^a KARLSTAD UNIVERSITY   (Sweden)

Author keywords

Drug use; Ethylphenidate; Internet drug; Legal high; Novel psychoactive substance; Research chemical

Indexed keywords

ETHYLPHENIDATE; PSYCHOSTIMULANT AGENT; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

ADULT; AGITATION; ANXIETY; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; COGNITION; COGNITIVE ENHANCEMENT; COGNITIVE FRAGMENTATION; COMPULSIVE DRUG REDOSING; DRUG ABUSE; DRUG ADMINISTRATION; DRUG DEPENDENCE; DRUG INFORMATION; DRUG MISUSE; DRUG SAFETY; EUPHORIA; FEMALE; HEART RATE; HUMAN; INDECISIVE; INTERNET; INTIMACY; MALE; MENTAL FUNCTION; MENTAL HEALTH; MUSCLE TONE; PLEASURE; RECREATION; SELF REPORT; SOCIAL ADAPTATION; SOCIAL INTERACTION; SWEATING;

EID: 84924965789     PISSN: None     EISSN: 11782218     Source Type: Journal    
DOI: 10.4137/SART.S22495     Document Type: Article

References (35)

1. Gibbons S. ‘Legal highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol. 2012;50(1):15–24.
2. Patrick KS, Corbin TR, Murphy CE. Ethylphenidate as a selective dopaminergic agonist and methylphenidate – ethanol transesterification biomarker. J Pharm Sci. 2014;103(12):3834–42.
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Europol 2011 annual report on the implementation of council decision 2005/387/JHA. 2012. Available at: http://www.emcdda.europa.eu/publications/implementation-reports/2011. Accessed October 16, 2014.
4. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The State of the Drugs Problem in Europe. 2012. Available at: http://www.emcdda.europa.eu/publications/annual-report/2012. Accessed October 16, 2014.
5. The Gallup Organization. Youth attitudes on drugs. Flash eurobarometer 330 analytical report. 2011. Luxembourg: European Commission.
6. Wood DM, Hunter L, Measham F, Dargan PI. Limited use of novel psychoactive substances in South London nightclubs. QJM. 2012;105(10):959–64.
7. Johnson LA, Johnson RL, Portier R. Current “legal highs”. J Emerg Med. 2013;44(6):1108–15.
8. King LA. Legal controls on cannabimimetics: an international dilemma? Drug Test Anal. 2013;6(1–2):80–7.
9. Markowitz JS, DeVane CL, Boulton DW, et al. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos. 2000;28(6):620–4.
10. Dresler M, Sandberg A, Ohla K, et al. Non-pharmacological cognitive enhancement. Neuropharmacology. 2013;64:529–43.
11. Farah MJ, Smith ME, Ilieva I, Hamilton RH. Cognitive enhancement. WIREs Cognit Sci. 2014;5(1):95–103.
12. Ragan CI, Bard I, Singh I. What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology. 2013;64:588–95.
13. Krueger J, Sachs H, Musshoff F, et al. First detection of ethylphenidate in human fatalities after ethylphenidate intake. Forensic Sci Int. 2014;243:126–9.
14. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014;87:150–60.
15. Markowitz JS, Logan BK, Diamond F, Patrick KS. Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion. J Clin Psychopharmacol. 1999;19(4):362–6.
16. Wood DM, Dargan PI. Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol. 2012;8(3):300–3.
17. Chiauzzi E, DasMahapatra P, Lobo K, Barratt MJ. Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views. Subst Use Misuse. 2013;48(8):661–70.
18. Móró L, Rácz J. Online drug user-led harm reduction in Hungary: a review of “Daath”. Harm Reduct J. 2013;10:18.
19. Soussan C, Kjellgren A. Harm reduction and knowledge exchange – a qualitative analysis of drug-related internet discussion forums. Harm Reduct J. 2014;11:25.
20. Kjellgren A, Jonsson K. Methoxetamine (MXE) – a phenomenological study of experiences induced by a “legal high” from the internet. J Psychoactive Drugs. 2013;45(3):276–86.
21. Kjellgren A, Soussan C. Heaven and hell – a phenomenological study of recreational use of 4-HO-MET in Sweden. J Psychoactive Drugs. 2011;45(3):276–86.
22. Soussan C, Kjellgren A. The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nord Stud Alcohol Drugs. 2014;31:207–20.
23. Borzekowski DL, Rickert VI. Adolescent cybersurfing for health information: a new resource that crosses barriers. JAMA Pediatr. 2001;155(7):813–7.
24. Gray NJ, Klein JD, Noyce PR, Sesselberg TS, Cantrill JA. Health information-seeking behavior in adolescence: the place of the internet. Soc Sci Med. 2005;60(7):1467–78.
25. Deluca P, Davey Z, Corazza O, et al. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:221–6.
26. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
27. Hayes N. Doing Psychological Research. Buckingham: Open University Press; 2000.
28. Secretary’s Advisory Committee on Human Research Protections (SACHRP). Considerations and Recommendations Concerning Internet Research and Human Subjects Research Regulations. Washington, D.C: U.S. Department of Health and Human Services; 2013.
29. Freeman TP, Morgan CJ, Vaughn-Jones J, Hussain N, Karimi K, Curran HV. Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’. Addiction. 2012;107(4):792–800.
30. Winstock A, Mitcheson L, Ramsey J, Davies S, Puchnarewicz M, Marsden J. Mephedrone: use, subjective effects and health risks. Addiction. 2011;106(11):1991–6.
31. Andrucci GL, Archer RP, Pancoast DL, Gordon RA. The relationship of MMPI and sensation seeking scales to adolescent drug use. J Pers Assess. 1989;53(2):253–66.
32. Walsh C. Drugs, the internet and change. J Psychoactive Drugs. 2011;43(1):55–63.
33. Barratt MJ, Allen M, Lenton S. “PMA sounds fun”: negotiating drug discourses online. Subst Use Misuse. 2014;49:987–98.
34. Hornik R, Jacobsohn L, Orwin R, Piesse A, Kalton G. Effects of the national youth anti-DRUG media campaign on youths. Am J Public Health. 2008;98(12):2229–36.
35. Crossley ML. Introduction to the symposium ‘health resistance’: the limits of contemporary health promotion. Health Educ J. 2002;61(2):101–12.